Rectal neuroendocrine tumor incidence ‘rapidly increasing’ in young adults, warrants study

By

CHICAGO — Incidence of rectal neuroendocrine tumors has increased in younger adults compared with older adults over the past 20 years, mostly driven by a rise in younger women, according to research presented at Digestive Disease Week.“Rectal neuroendocrine tumors are heterogenous neoplasms of neuroendocrine cells in the rectum that can secrete bioactive peptides,” Yazan Abboud,…

Combination of patient, provider outreach boosts CRC screening in high-risk individuals

By

CHICAGO — A multicomponent strategy, which included patient and provider outreach, increased colorectal cancer screening in individuals overdue for colonoscopy who have a family history of CRC, according to data at Digestive Disease Week.“In the United States, CRC is the third most diagnosed cancer and the second most common cause of cancer-related mortality,” Shailavi Jain,…

1 in 6 early-onset colorectal cancer survivors diagnosed with subsequent cancer

By

CHICAGO — Among those who survived early-onset colorectal cancer, approximately 16% developed a second cancer, with higher risk reported among men, according to a population-based study presented at Digestive Disease Week.“The number of cancer survivors is increasing and is projected to grow to 26 million by 2040 in the United States,” Aniruddha Rathod, PhD, MBBS,…

Ileocecal resection may have role as ‘primary treatment’ in recently diagnosed Crohn’s

By

CHICAGO — Patients who underwent ileocecal resection for Crohn’s disease had a 33% lower risk for hospitalization, repeat surgery, systemic corticosteroid exposure and perianal CD, according to a presenter at Digestive Disease Week.“The LIR!C trial has demonstrated comparable quality of life with ileocecal resection compared to infliximab as a first-line treatment for limited, non-stricturing ileocecal…